19 September 2023 in Advanced Healthcare Materials
23 March 2021 in Cell Proliferation
Objectives: ZFP91, an E3 ligase, has been reported to possess cancer‐promoting functions. This study aimed to elucidate the exact role of ZFP91 in tumour progression of pancreatic cancer and underlying mechanisms.Materials and Methods: We analysed the correlation between ZFP91 expression and pancreatic cancer through TCGA and GEO data sets. Growth curve, colony formation, wound healing and transwell invasion assays were conducted to evaluate proliferation, migration and invasion of lentivirus transfected pancreatic cancer cells. GSEA and Western blot analysis were performed to validate the regulatory effect of ZFP91 on β‐catenin. Drug response curve and orthotopic implantation model reflected the sensitivity of chemotherapies.Results: ZFP91 overexpression is prevalent in pancreatic cancer and negatively correlated with overall survival. ZFP91 knock‐down attenuated proliferation, migration and invasion of pancreatic cancer cells. β‐catenin was a downstream gene of ZFP91, and its agonist could reverse the phenotype. ZFP91 promoted EMT and chemoresistance in pancreatic cancer.Conclusions: We demonstrated that ZFP91 promoted pancreatic cancer proliferation, migration and invasion through activating β‐catenin signalling. EMT and chemoresistance were also regulated by ZFP91. ZFP91 might be a potential therapeutic target for pancreatic cancer.
28 May 2025 in Advanced Functional Materials
1 January 2025 in Engineered Regeneration
12 December 2023 in Research Square
Objective To explore the cross-sectional relationship between exposure to Environmental Endocrine Disruptors (EEDs) and Henoch-Schoenlein Purpura Nephritis (HSPN) risk in Children. Methods This was a retrospective case-control study of 31 pediatric patients with diagnosed HSPN and 30 normal children through routine physical examination. All Participants' basic characteristics, clinical indicators were collected from January 2020 to December 2023 at our pediatric centers. Residues of related endocrine disruptors in the urine were detected by liquid chromatography. Logistic regression analysis was used to confirm the correlation between the results of each index and HSPN. The role of endocrine disruptors in early screening of HSPN was confirmed by ROC curve analysis. Results In age, and BMI-adjusted models, the levels of several EEDs in urine samples in the disease group were generally higher than those in the control group [OR = 3.16; 95% CI: 1.14–8.76]. BPA, Benzo(a)pyrene, Zearalenone, lead, and MEHP in urine samples from patients were significantly higher than those from healthy controls. The multivariate logistic regression showed that Benzo(a)pyrene (OR = 1.03; 95% CI: 1.01–1.04; p < .001), MEHP (OR = 1.0; 95% CI: 1.0–1.0; p < .001), Zearalenone (OR = 1.03; 95% CI: 1.01–1.05; p < .001), Lead (OR = 1.03; 95% CI: 1.00–1.00; p < .001) and BPA (OR = 1.01; 95% CI:1.00–1.01; p < .001) were significantly associated with the occurrence of HSPN. The ROC curve indicated that Benzo(a)pyrene (AUC = 0.83; p < .001), MEHP (AUC = 0.83; p < .001), Zearalenone (AUC = 0.70; p = 0.006), Lead (AUC = 0.69; p = 0.008) and BPA (AUC = 0.84; p < .001) have good early screening ability for predicting the pathogenesis of HSPN. Conclusions Our results suggest a link between environmental exposures to EEDs and HSPN. Benzo(a)pyrene, MEPH, Zearalenone, BPA, and Lead were associated with an increased risk of HSPN. These EEDs also have good early screening ability for predicting the pathogenesis of HSPN.